These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8907296)

  • 1. The platelet aggregation in children with epilepsy receiving valproic acid.
    Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
    Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.
    Serdaroglu G; Tütüncüoglu S; Kavakli K; Tekgül H
    J Child Neurol; 2002 Jan; 17(1):41-3. PubMed ID: 11913569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDTA-dependent pseudothrombocytopenia induced by valproic acid.
    Yoshikawa H
    Neurology; 2003 Aug; 61(4):579-80. PubMed ID: 12939450
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet count and function in children receiving sodium valproate.
    Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
    Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of valproic acid monotherapy correlates with subclinical thyroid dysfunction in children with epilepsy.
    Ilić V; Bogićević D; Miljković B; Ješić M; Kovačević M; Prostran M; Kovačević SV
    Epileptic Disord; 2016 Jun; 18(2):181-6. PubMed ID: 27099936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid and immune thrombocytopenia.
    Barr RD; Copeland SA; Stockwell ML; Morris N; Kelton JC
    Arch Dis Child; 1982 Sep; 57(9):681-4. PubMed ID: 6812506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced bleeding: report of two cases and review of literature.
    Kumar S
    Indian Pediatr; 2005 Aug; 42(8):833-4. PubMed ID: 16141489
    [No Abstract]   [Full Text] [Related]  

  • 11. An Evaluation of Peripapillary Retinal Nerve Fiber Layer Thickness in Children With Epilepsy Receiving Treatment of Valproic Acid.
    Dereci S; Koca T; Akçam M; Türkyilmaz K
    Pediatr Neurol; 2015 Jul; 53(1):53-7. PubMed ID: 25979661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review.
    Sinclair DB; Berg M; Breault R
    J Child Neurol; 2004 Jul; 19(7):498-502. PubMed ID: 15526953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
    Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid.
    Kulhas Celik I; Tasdemir HA; Ince H; Celik H; Sungur M
    Clin Neurol Neurosurg; 2018 Jul; 170():106-112. PubMed ID: 29772401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet dysfunction in children during treatment with sodium valproate].
    Ikeda N; Mitsudome A; Ogata H; Ohfu M
    No To Hattatsu; 1984 Jan; 16(1):27-31. PubMed ID: 6424693
    [No Abstract]   [Full Text] [Related]  

  • 18. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
    Verrotti A; Greco R; Morgese G; Chiarelli F
    Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid (Depakene). A new anticonvulsant agent.
    Lewis JR
    JAMA; 1978 Nov; 240(20):2190-2. PubMed ID: 100622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of haemostasis in children treated with valproic acid].
    Schädlich D; Friebel D; Schallner J; Gehrisch S; Siegert G; Kuhlisch E; Knöfler R
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S132-7. PubMed ID: 21042677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.